PF-06252616 Uses, Dosage, Side Effects and more
PF-06252616 is under investigation in clinical trial NCT01616277 (A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects).
| Attribute | Details |
|---|---|
| Trade Name | PF-06252616 |
| Generic | Domagrozumab |
| Domagrozumab Other Names | Domagrozumab, PF-06252616 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
